Home > Insider Trading > Filing (0001209191-17-009742)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1497253	Organovo Holdings Inc.	ONVO	Biological Products, (No Disgnostic Substances) (2836)	271488943

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1536583	Keith Murphy	6275 Nancy Ridge Drive, Suite 110 San Diego CA 92121	Chairman, Ceo And President	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-02-08	30,000	$1.00	6,068,915	No	4	M	Indirect	IRA
Common Stock	Disposition	2017-02-09	25,000	$3.68	6,043,915	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Indirect	IRA
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant	Disposition	2017-02-08	30,000	$0.00	30,000	$1.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2012-02-08	2017-02-08	No	4	M	Direct

Footnotes

The Warrants are held by the Equity Trust Co. Custodian FBO Keith Murphy IRA.
The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $3.63 to $3.74. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
This number does not include 1,831,454 shares of common stock underlying outstanding options held by Mr. Murphy; post-transaction Mr. Murphy continues to beneficially own or have a right to acquire 7,875,369 shares of common stock.
The Reporting Person exercised warrants to purchase 30,000 shares of the Issuer's common stock for $1.00 a share. The warrant would have expired by its terms if not exercised by the Reporting Person on February 8, 2017.